论文部分内容阅读
白血病细胞存在于循环血液中,很容易与靶向性药物直接接触。脂质体(liposome)由于其负荷量大,对机体无毒性,已被越来越广泛地用作药物的载体。单克隆抗体(单抗)的问世使制备免疫脂质体(immunoliposome)成为可能。这种脂质体由于针对特异抗原的单抗的
Leukemia cells are present in circulating blood and are easily in direct contact with targeted drugs. Liposomes have been used more and more widely as carriers for drugs because of their large load and no toxicity to the body. The advent of monoclonal antibodies (monoclonal antibodies) has made it possible to prepare immunoliposomes. This liposome is due to a monoclonal antibody against a specific antigen